SavedAdd your journal

Journals / Journal of Health Sciences and Medicine / 2021 / Cilt: 4 - Sayı: 3

COVID-19 and myocarditis/myocardial injury

Kaan OKYAY
Pages
388–390
Publication Date
2021-05-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Still, multidisciplinary trials are needed to explain this important situation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myocarditis is defined as inflammation of the myocardium, and it presents with different clinical pictures, and its diagnosis has some difficulties.
📊
Key Findings & Data:SARS-CoV-2 affects cardiovascular systems directly or via indirectly mechanisms.
💡
Conclusion & Impact:Still, multidisciplinary trials are needed to explain this important situation.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 infection · myocardial injury · myocarditis

Abstract

Myocarditis is defined as inflammation of the myocardium, and it presents with different clinical pictures, and its diagnosis has some difficulties. The prognosis of myocarditis is aetiology-dependent, and treatment is fundemantally supportive except for “endometrial biopsy proven” cases which requires spesific therapies including immunomodulators and intravenous immunoglobulins. SARS-CoV-2 affects cardiovascular systems directly or via indirectly mechanisms. COVID-19 infection increases the risks of myocardial injury, myocarditis, myocardial infarction, heart failure, venous thromboembolism and arrhythmias. The underlying mechanism of troponin elevation during COVID-19 infections is not exactly explained. In this review, the relationship between COVID-19 and myocardial involvement was discussed. Still, multidisciplinary trials are needed to explain this important situation.

🔖

Cite This Article

OKYAY, K. (2021). COVID-19 and myocarditis/myocardial injury. Journal of Health Sciences and Medicine, Cilt: 4 - Sayı: 3, 388–390. https://ajindex.com/articles/776959

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Turkish Cardiology Association Consensus Report: COVID-19 Pandemic and Cardiovascular Diseases. Turk Kardiyol Dern Ars 2020; 48: 1-87.
  2. Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 2020; 17: 1463-71.
  3. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5: 811-8.
  4. Hendren NS, Drazner MH, Bozkurt B and Cooper LT, Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 2020; 141: 1903-14.
  5. Pirzada A, Mokhtar AT, Moeller AD. COVID-19 and myocarditis: what do we know so far? CJC Open 2020; 2: 278-85.
  6. Kawakami R, Sakamoto A, Kawai K, et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis. J Am Coll Cardiol 2021; 77: 314-25.
  7. Okyay K, Sadıç BÖ, Şahinarslan A, et al. Turkish Society of Cardiology consensus paper on the rational use of cardiac troponins in daily practice. Anatol J Cardiol 2019; 21: 331-44.
  8. Skulstad H, Cosyns B, Popescu BA, et al. EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging 2020; 21: 592-8.
  9. Pellegrini D, Kawakami R, Guagliumi G, et al. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation 2021; 143: 1031-42.
  10. Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 2021: ehab075.